Ribociclib Succinate
Brand name: Kisqali
Rank #172 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$90.3M
Total Cost
5,978
Total Claims
$90.3M
Total Cost
331
Prescribers
$15K
Cost per Claim
38
Beneficiaries
5,989
30-Day Fills
$273K
Avg Cost/Provider
18
Avg Claims/Provider
Share of Medicare Part D Spending
0.03%
of total Medicare Part D spending
$90.3M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $90.3M total
🔎 Data Overview
At $15,098 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $272,682 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $2,375,201 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Ribociclib Succinate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Antoine Chahine | Medical Oncology | Canfield, OH | 69 | $1.2M |
| 2 | Qamar Khan | Hematology-Oncology | Westwood, KS | 74 | $1.2M |
| 3 | Luis Baez Vallecillo | Hematology-Oncology | San Juan, PR | 73 | $941K |
| 4 | Kumar Abhishek | Hematology-Oncology | Mechanicsville, VA | 54 | $930K |
| 5 | Lawrence Gynther | Hematology-Oncology | Lagrange, GA | 51 | $899K |
| 6 | Nikita Shah | Hematology-Oncology | Orlando, FL | 51 | $828K |
| 7 | Noman Rafique | Hematology-Oncology | Massillon, OH | 46 | $797K |
| 8 | Andrew Davis | Medical Oncology | Florissant, MO | 49 | $797K |
| 9 | Wajeeha Razaq | Hematology-Oncology | Oklahoma City, OK | 53 | $755K |
| 10 | Melanie Clark | Hematology-Oncology | Fort Wayne, IN | 53 | $736K |
| 11 | Teresa Helsten | Hematology-Oncology | La Jolla, CA | 50 | $707K |
| 12 | Nicole Williams | Medical Oncology | Columbus, OH | 45 | $638K |
| 13 | Brooke Gillett | Hematology-Oncology | Springfield, MO | 47 | $621K |
| 14 | Ibrahim Shalaby | Hematology-Oncology | Lubbock, TX | 36 | $603K |
| 15 | Philomena Mcandrew | Hematology-Oncology | Beverly Hills, CA | 36 | $573K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 169 | Trazodone Hcl (Trazodone Hcl) | $92.6M | 7,273,528 |
| 170 | Insulin Glargine/Lixisenatide (Soliqua 100-33) | $92.5M | 82,886 |
| 171 | Latanoprost (Latanoprost) | $92.3M | 4,388,601 |
| 172 | Ribociclib Succinate (Kisqali) | $90.3M | 5,978 |
| 173 | Lacosamide (Lacosamide) | $90.1M | 300,038 |
| 174 | Mepolizumab (Nucala) | $90.1M | 20,798 |
| 175 | Finerenone (Kerendia) | $89.5M | 93,151 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology